Alcon Inc

Research Alcon Inc (ALC) on Bullrun: valuation model: 22.6% overvalued, market cap USD 32.97B, P/E 40.8, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALC
• ExchangeNYSE
• CountrySwitzerland
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyUSD
• Valuation signal22.6% overvalued
• Market capUSD 32.97B
• P/E40.8
• Dividend yield0.5%
• Financial periodFY2010
• RevenueUSD 7.18B
• Revenue growth10.5%
• Net incomeUSD 2.21B
• Free cash flowUSD 2.07B
• Gross margin76.7%

Valuation Snapshot

Bullrun's latest valuation model marks Alcon Inc as 22.6% overvalued; latest market cap is USD 32.97B; P/E is 40.8; dividend yield is 0.5%.

About Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Frequently asked questions

Is Alcon Inc overvalued or undervalued?

Bullrun's valuation model currently marks Alcon Inc as 22.6% overvalued.

What is Alcon Inc's market cap?

Alcon Inc's market capitalization is USD 32.97B.

What is Alcon Inc's P/E ratio?

Alcon Inc's price-to-earnings (P/E) ratio is 40.8.

Does Alcon Inc pay a dividend?

Alcon Inc has a dividend yield of 0.5%.

What does Alcon Inc do?

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables;